• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Inspections, Compliance, Enforcement, and Criminal Investigations

  • Print
  • Share
  • E-mail

Monarch Med Spa - Close Out Letter 5/21/10


Department of Health and Human Services' logoDepartment of Health and Human Services

Public Health Service
Food and Drug Administration
  Silver Spring, MD 20993



May 21, 2010


Mr. Kevin Campbell, President & CEO
Monarch Med Spa
Oak Hill Plaza
200 N. Warner Road, Suite 121
King of Prussia, PA 19406


Dear Mr. Campbell:

The Food and Drug Administration has completed an evaluation of your firm's corrective actions in response to our Warning Letter dated April 5, 2010. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA follow-up and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.




Michael M. Levy, Jr., Esq.
Division of New Drugs & Labeling Compliance
Office of Compliance
Center for Drug Evaluation and Research

cc: Ely Goldin
Fox Rothschild LLP
10 Sentry Parkway, Suite 200
P.O. Box 3001
Blue Bell, PA 19422

Kirk Sooter, District Director
Philadelphia District Office, HFR-CE100
900 US Customhouse
200 Chestnut St.
Philadelphia, PA 19106

Steven L. Carter, Director Compliance Branch
Philadelphia District Office, HFR-CE140
900 US Customhouse
200 Chestnut St.
Philadelphia, PA 19106